SCHEMBL29458593

SCHEMBL29458593

CC(CF)NCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)CCF)cc4)cnc3N)on2)c(F)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ATR Q13535 20/20 0.60
ATM Q13315 10/20 0.60
PRKDC P78527 5/20 0.60
GSK3B P49841 3/20 0.58
JAK2 O60674 1/20 0.58
ABL1 P00519 1/20 0.58
KIT P10721 1/20 0.58
SERPINA2 P20848 1/20 0.58
PIK3R1 P27986 1/20 0.58
FLT4 P35916 1/20 0.58
FLT3 P36888 1/20 0.58
PIK3CA P42336 1/20 0.58
MTOR P42345 1/20 0.58
SYK P43405 1/20 0.58
GSK3A P49840 1/20 0.58
MAP3K9 P80192 1/20 0.58
KCNH2 Q12809 1/20 0.58
MERTK Q12866 1/20 0.58
DYRK2 Q92630 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057057 1.00 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL3042027 0.95 ATR (0.59) ATRATMPRKDCGSK3BJAK2
SCHEMBL29458700 0.95 ATR (0.59) ATRATMPRKDCGSK3BJAK2
SCHEMBL29458632 0.93 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL3049841 0.93 ATR (0.60) ATRATMPRKDCGSK3BJAK2
SCHEMBL3057808 0.93 ATR (0.69) ATRATMPRKDCGSK3BJAK2
SCHEMBL29458628 0.93 ATR (0.67) ATRATMPRKDCGSK3BJAK2
SCHEMBL3056605 0.93 ATR (0.67) ATRATMPRKDCGSK3BJAK2
SCHEMBL3056573 0.92 ATR (0.71) ATRATMPRKDCGSK3BJAK2
SCHEMBL3051511 0.91 ATR (0.61) ATRATMPRKDCGSK3BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4059932-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Incorporated (US) 2022-09-21 EP disclosed
EP-3354650-B1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMA (US) 2022-02-16 EP disclosed